Kolexia
Boulanger Thomas
Radio-diagnostic
Hôpital Seclin Carvin
Seclin, France
60 Activités
360 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Métastase tumorale Tumeurs du sein Méningite Méningite carcinomateuse Tumeurs des méninges Mélanome Carcinomes Maladie de Fabry Tumeurs du foie

Industries

M3 Global Research Ltd
10 collaboration(s)
Dernière en 2023
B3TSI
8 collaboration(s)
Dernière en 2022
WorldOne
4 collaboration(s)
Dernière en 2020
AstraZeneca
2 collaboration(s)
Dernière en 2023

Dernières activités

Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX).
Cancers   28 mars 2023
Lésions classées ACR 3 en mammographie
Imagerie de la Femme   01 septembre 2022
Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer.
Neuro-oncology   27 avril 2021
The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal.
Neuro-oncology   19 août 2020
D07 SIOP19-0845 Cilengitide (EMD121974) in Combination with Irradiation in Children and Young Adults with Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Phase I Study
Abstracts from the 51st Congress of the International Society of Paediatric Oncology (SIOP) Lyon, France, October 23–26, 2019   30 septembre 2019
DEPOSEIN: Role of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Patients Wih Leptomeningeal Metastasis of Breast Cancer. A Randomized Phase III Study.
Essai Clinique (Centre Oscar-Lambret)   11 juin 2019
Validation and revision of the RANO Leptomeningeal Metastasis Group scorecard for response assessment.
2019 ASCO Annual Meeting I   26 mai 2019
French program of breast cancer screening: Radiologist viewpoint.
Bulletin du cancer   30 avril 2019
CMET-39. INTRA-CSF LIPOSOMAL CYTARABINE PLUS SYSTEMIC THERAPY AS INITIAL TREATMENT OF BREAST CANCER LEPTOMENINGEAL METASTASIS: A RANDOMISED, OPEN-LABEL TRIAL
Abstracts from the 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology November 15 – 18, 2018 New Orleans, Louisiana   05 novembre 2018
Intra-CSF liposomal cytarabine plus systemic therapy as initial treatment of breast cancer leptomeningeal metastasis: A randomised, open-label trial
Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany   01 octobre 2018